H.C. Wainwright Reiterates Buy Rating on Larimar Therapeutics (LRMR)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| (NASDAQ: LRMR) | Delayed: 2.31 -0.11 (4.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.42 | 52 Week High | $ | |||
| Open | $2.40 | 52 Week Low | $ | |||
| Day High | $2.51 | P/E | N/A | |||
| Day Low | $2.25 | EPS | $ | |||
| Volume | 797,339 | |||||
